Shanghai Fudan Forward S&T Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Fudan Forward S&T Co Ltd with three other
companies in this sector in China:
Shandong Wohua Pharmaceutical Co., Ltd.
sales of 726.65 million Chinese Renmimbi [US$105.55 million]
of which 100%
was Medical Industry),
Wuhan Hiteck Biological Pharma Co Ltd
(750.26 million Chinese Renmimbi [US$108.98 million]
of which 99%
was Medicine Manufacture), and
Beijing Science Sun Pharmaceutical Co Ltd
(749.99 million Chinese Renmimbi [US$108.94 million]
of which 100%
was Phamaceutical Manufacturing Industry).
During the year ended December of 2017, sales at
Shanghai Fudan Forward S&T Co Ltd were 735.73 million Chinese Renmimbi (US$106.87 million).
increase of 9.7%
versus 2016, when the company's sales were 670.57 million Chinese Renmimbi.
Sales of Industrial saw an increase
that was more than double the company's growth rate: sales were up
24.6% in 2017, from
375.09 million Chinese Renmimbi to 467.30 million Chinese Renmimbi.
Not all segments of Shanghai Fudan Forward S&T Co Ltd experienced an increase in sales in 2017:
sales of Other Operations fell 65.7% to 12.49 million Chinese Renmimbi.
Shanghai Fudan Forward S&T Co Ltd also experienced decreases in sales in
Software Development (down 11.0% to 231.21 million Chinese Renmimbi)